Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infection

1 Jan 2022

Abstract excerpt

Abstract Background A well-known blood biomarker (soluble fms-like tyrosinase-1 [sFLT-1]) for preeclampsia, i.e., a pregnancy disorder, was found to predict severe COVID-19, including in males. True biomarker may be masked by more-abrupt changes related to endothelial instead of placental dysfunction. This study aimed to identify blood biomarkers that represent maternal-fetal interface tissues for predicting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Impact on Reproduction
Share to Gestational Diabetes Research and Management
Share to Pregnancy and preeclampsia studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35966044
DOI: 10.1016/j.csbj.2022.08.011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood biomarkers representing maternal-fetal interface tissues used to predict early-and late-onset preeclampsia but not COVID-19 infectionPMID 35966044Read ↗

Improved Prediction Accuracy for Late-Onset Preeclampsia Using cfRNA Profiles: A Comparative Study of Marker Selection StrategiesSemantic proximity Read ↗

Molecular subtyping of hypertensive disorders of pregnancySemantic proximity Read ↗

An updated view on the origin and use of angiogenic biomarkers for preeclampsiaSemantic proximity Read ↗

Early pathways, biomarkers, and four distinct molecular subclasses of preeclampsia: The intersection of clinical, pathological, and high-dimensional biology studiesSemantic proximity Read ↗

RNA profiles reveal signatures of future health and disease in pregnancySemantic proximity Read ↗

A cost-effective machine learning-based method for preeclampsia risk assessment and driver genes discoverySemantic proximity Read ↗

Characterizing immune variation and diagnostic indicators of preeclampsia by single-cell RNA sequencing and machine learningSemantic proximity Read ↗

Integration of Single-Cell Sequencing and Transcriptomic Analysis to Identify Novel Diagnostic Biomarkers for Preeclampsia and Explore Changes in Immune Cell InteractionsSemantic proximity Read ↗

Systemic transcriptome comparison between early‐ And late‐onset pre‐eclampsia shows distinct pathology and novel biomarkersSemantic proximity Read ↗

Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal studySemantic proximity Read ↗

Uncovering serum placental-related non-coding RNAs as possible biomarkers of preeclampsia risk, onset and severity revealed MALAT-1, miR-363 and miR-17Semantic proximity Read ↗

Development and validation of preeclampsia predictive models using key genes from bioinformatics and machine learning approachesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.